Related Experiment Video
Updated: Nov 26, 2025

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
[Off label uses of tigecycline]
A Ben Mabrouk1, H Ben Brahim1, I Kooli1
1University Hospital Fattouma Bourguiba of Monastir, Infectious Diseases Department, 5019 Monastir, Tunisie.
Tigecycline, an antibiotic with limited approved uses, shows promising off-label results for multi-resistant infections. However, evidence for many uses is insufficient, and off-label prescriptions may increase mortality and side effects.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Tigecycline is a novel antibiotic with restricted approved indications.
- It is frequently used off-label for various infections when other treatments fail.
- This off-label use often yields promising clinical outcomes.
Purpose of the Study:
- To review and summarize the off-label applications of tigecycline.
- To provide guidance on appropriate prescribing in the absence of formal guidelines.
- To evaluate the efficacy and safety of tigecycline in diverse clinical scenarios.
Main Methods:
- A comprehensive literature review was conducted.
- Articles focusing on the off-label use of tigecycline were systematically collected and analyzed.
Main Results:
- Tigecycline demonstrated respectable evidence for treating pneumonia off-label.
- Data for other indications were insufficient, with varied treatment protocols hindering efficacy evaluation.
- Off-label tigecycline use was associated with increased mortality and side effects, with a trend towards higher dosages.
Conclusions:
- Tigecycline remains a valuable option for multi-drug resistant bacterial infections.
- It is particularly useful when alternative treatments are limited or in patients with renal failure.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Destabilize Microtubules
Tumor Immunotherapy
Drugs that Stabilize Microtubules

